On Invalid Date, Context Therapeutics (NASDAQ: CNTX) reported Q4 2023 earnings per share (EPS) of -$0.42, up 90.91% year over year. Total Context Therapeutics earnings for the quarter were -$6.77 million. In the same quarter last year, Context Therapeutics's earnings per share (EPS) was -$0.22.
As of Q2 2024, Context Therapeutics's earnings has grown year over year. Context Therapeutics's earnings in the past year totalled -$23.96 million.
What is CNTX's earnings date?
Context Therapeutics's earnings date is Invalid Date. Add CNTX to your watchlist to be reminded of CNTX's next earnings announcement.
What was CNTX's revenue last quarter?
On Invalid Date, Context Therapeutics (NASDAQ: CNTX) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Context Therapeutics's revenue was $0.00.
What was CNTX's revenue growth in the past year?
As of Q2 2024, Context Therapeutics's revenue has grown null year over year. Context Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.